TMEM173 is a biomarker of predicting prognosis, immune responses and therapeutic effect in human Lung AdenocarcinomaBo Li(Army Medical University), Pingting Zhou(Shanghai Ninth People's Hospital)Research SquareNovember 1, 202310.21203/rs.3.rs-3507880/v1Cited by 0SaveCiteExport RISWatch citationsRelated PapersDichloroacetate and metformin synergistically suppress the growth of ovarian cancer cells|Oncotarget|2016|52MicroRNA-101-3p advances cisplatin sensitivity in bladder urothelial carcinoma through targeted silencing EZH2|Journal of Cancer|2019|33